{
  "analysis_metadata": {
    "timestamp": "2025-06-16T12:56:27.031617",
    "database": "mediabase",
    "transcript_count": 3,
    "analysis_version": "v1.0.0"
  },
  "drug_gene_interactions": {
    "total_drug_interactions": 4,
    "druggable_genes_count": 3,
    "high_score_targets": 2,
    "mechanism_distribution": {
      "inhibitor": 1,
      "competitive inhibitor": 1,
      "irreversible inhibitor": 1,
      "allosteric modulator": 1
    },
    "score_statistics": {
      "mean": 115.675,
      "median": 113.85,
      "max": 156.7,
      "min": 78.3
    },
    "top_drug_targets": [
      {
        "gene_symbol": "CTSL",
        "transcript_id": "ENST00000343150.10",
        "drug_id": "2341",
        "drug_name": "Cathepsin L inhibitor CLI-23",
        "score": 156.7,
        "mechanism": "irreversible inhibitor",
        "chromosome": "chr9"
      },
      {
        "gene_symbol": "UBE2I",
        "transcript_id": "ENST00000566587.6",
        "drug_id": "4344",
        "drug_name": "Drug compound 4344",
        "score": 138.5,
        "mechanism": "inhibitor",
        "chromosome": "chr16"
      }
    ],
    "clinical_summary": "Analysis identified 4 drug-gene interactions across multiple therapeutic modalities. Highest therapeutic potential: CTSL (score: 156.7). These interactions represent immediate opportunities for precision medicine approaches."
  },
  "pathway_enrichment": {
    "total_pathways": 9,
    "enriched_pathways": [
      {
        "pathway": "Nuclear Envelope Reassembly",
        "gene_count": 1,
        "enrichment_score": 33.33333333333333,
        "genes": [
          "UBE2I"
        ]
      },
      {
        "pathway": "SUMO modification",
        "gene_count": 1,
        "enrichment_score": 33.33333333333333,
        "genes": [
          "UBE2I"
        ]
      },
      {
        "pathway": "Cell cycle regulation",
        "gene_count": 1,
        "enrichment_score": 33.33333333333333,
        "genes": [
          "UBE2I"
        ]
      },
      {
        "pathway": "Glycosylation",
        "gene_count": 1,
        "enrichment_score": 33.33333333333333,
        "genes": [
          "SLC35A2"
        ]
      },
      {
        "pathway": "Galactose metabolism",
        "gene_count": 1,
        "enrichment_score": 33.33333333333333,
        "genes": [
          "SLC35A2"
        ]
      },
      {
        "pathway": "ER-Golgi transport",
        "gene_count": 1,
        "enrichment_score": 33.33333333333333,
        "genes": [
          "SLC35A2"
        ]
      },
      {
        "pathway": "Autophagy",
        "gene_count": 1,
        "enrichment_score": 33.33333333333333,
        "genes": [
          "CTSL"
        ]
      },
      {
        "pathway": "Lysosomal protein degradation",
        "gene_count": 1,
        "enrichment_score": 33.33333333333333,
        "genes": [
          "CTSL"
        ]
      },
      {
        "pathway": "Antigen processing",
        "gene_count": 1,
        "enrichment_score": 33.33333333333333,
        "genes": [
          "CTSL"
        ]
      }
    ],
    "pathway_cooccurrence_network": [],
    "pathway_statistics": {
      "mean_genes_per_pathway": 1,
      "max_pathway_size": 1
    },
    "clinical_summary": "Primary pathway alteration: Nuclear Envelope Reassembly (1 genes, 33.3% enrichment). Pathway-targeted therapies should be prioritized for clinical intervention."
  },
  "functional_classification": {
    "molecular_function_landscape": {
      "total_functions": 7,
      "top_functions": {
        "ATP binding": 1,
        "SUMO conjugating enzyme activity": 1,
        "protein binding": 1,
        "UDP-galactose transmembrane transporter activity": 1,
        "carbohydrate transmembrane transporter activity": 1,
        "cysteine-type endopeptidase activity": 1,
        "peptidase activity": 1
      },
      "functional_profiles": [
        {
          "molecular_function": "ATP binding",
          "gene_count": 1,
          "primary_locations": {
            "PML body": 1,
            "transferase complex": 1,
            "nuclear envelope": 1
          },
          "frequency_score": 33.33333333333333
        },
        {
          "molecular_function": "SUMO conjugating enzyme activity",
          "gene_count": 1,
          "primary_locations": {
            "PML body": 1,
            "transferase complex": 1,
            "nuclear envelope": 1
          },
          "frequency_score": 33.33333333333333
        },
        {
          "molecular_function": "protein binding",
          "gene_count": 1,
          "primary_locations": {
            "PML body": 1,
            "transferase complex": 1,
            "nuclear envelope": 1
          },
          "frequency_score": 33.33333333333333
        },
        {
          "molecular_function": "UDP-galactose transmembrane transporter activity",
          "gene_count": 1,
          "primary_locations": {
            "Golgi apparatus": 1,
            "endoplasmic reticulum membrane": 1
          },
          "frequency_score": 33.33333333333333
        },
        {
          "molecular_function": "carbohydrate transmembrane transporter activity",
          "gene_count": 1,
          "primary_locations": {
            "Golgi apparatus": 1,
            "endoplasmic reticulum membrane": 1
          },
          "frequency_score": 33.33333333333333
        },
        {
          "molecular_function": "cysteine-type endopeptidase activity",
          "gene_count": 1,
          "primary_locations": {
            "lysosome": 1,
            "cytoplasm": 1,
            "extracellular region": 1
          },
          "frequency_score": 33.33333333333333
        },
        {
          "molecular_function": "peptidase activity",
          "gene_count": 1,
          "primary_locations": {
            "lysosome": 1,
            "cytoplasm": 1,
            "extracellular region": 1
          },
          "frequency_score": 33.33333333333333
        }
      ]
    },
    "cellular_location_distribution": {
      "PML body": 1,
      "transferase complex": 1,
      "nuclear envelope": 1,
      "Golgi apparatus": 1,
      "endoplasmic reticulum membrane": 1,
      "lysosome": 1,
      "cytoplasm": 1,
      "extracellular region": 1
    },
    "product_type_classification": {
      "cytoplasmic": 1,
      "nuclear": 1,
      "rna_binding": 1,
      "transmembrane": 1,
      "transporter": 1,
      "hydrolase": 1,
      "lysosomal": 1
    },
    "go_molecular_functions": {
      "ATP binding": 1,
      "SUMO conjugating enzyme activity": 1,
      "UDP-galactose transmembrane transporter activity": 1,
      "cysteine-type endopeptidase activity": 1
    },
    "clinical_summary": "Dominant functional alteration: ATP binding (1 genes affected). Functional targeting strategies should focus on this domain."
  },
  "chromosomal_distribution": {
    "chromosomal_distribution": [
      {
        "chromosome": "chr16",
        "gene_count": 1,
        "drug_targets": 1,
        "density_score": 33.33333333333333,
        "position_range": {
          "start": 1309638,
          "end": 1309638,
          "span": 0
        }
      },
      {
        "chromosome": "chrX",
        "gene_count": 1,
        "drug_targets": 1,
        "density_score": 33.33333333333333,
        "position_range": {
          "start": 48394442,
          "end": 48394442,
          "span": 0
        }
      },
      {
        "chromosome": "chr9",
        "gene_count": 1,
        "drug_targets": 2,
        "density_score": 33.33333333333333,
        "position_range": {
          "start": 87850654,
          "end": 87850654,
          "span": 0
        }
      }
    ],
    "hotspot_chromosomes": [
      {
        "chromosome": "chr16",
        "gene_count": 1,
        "drug_targets": 1,
        "density_score": 33.33333333333333,
        "position_range": {
          "start": 1309638,
          "end": 1309638,
          "span": 0
        }
      },
      {
        "chromosome": "chrX",
        "gene_count": 1,
        "drug_targets": 1,
        "density_score": 33.33333333333333,
        "position_range": {
          "start": 48394442,
          "end": 48394442,
          "span": 0
        }
      },
      {
        "chromosome": "chr9",
        "gene_count": 1,
        "drug_targets": 2,
        "density_score": 33.33333333333333,
        "position_range": {
          "start": 87850654,
          "end": 87850654,
          "span": 0
        }
      }
    ],
    "drug_target_chromosomes": [
      [
        "chr9",
        2
      ],
      [
        "chr16",
        1
      ],
      [
        "chrX",
        1
      ]
    ],
    "distribution_statistics": {
      "total_chromosomes": 3,
      "mean_genes_per_chromosome": 1,
      "hotspot_threshold": 33.33333333333333
    },
    "clinical_summary": "Primary chromosomal hotspot: chr16 (1 genes, 33.3% density). Cytogenetic analysis and chromosomal stability assessment recommended."
  },
  "multimodal_integration": {
    "integrated_gene_profiles": [
      {
        "gene_symbol": "CTSL",
        "transcript_id": "ENST00000343150.10",
        "chromosome": "chr9",
        "has_drugs": true,
        "drug_count": 2,
        "pathway_count": 3,
        "function_count": 2,
        "multimodal_score": 14
      },
      {
        "gene_symbol": "UBE2I",
        "transcript_id": "ENST00000566587.6",
        "chromosome": "chr16",
        "has_drugs": true,
        "drug_count": 1,
        "pathway_count": 3,
        "function_count": 3,
        "multimodal_score": 12
      },
      {
        "gene_symbol": "SLC35A2",
        "transcript_id": "ENST00000634461.1",
        "chromosome": "chrX",
        "has_drugs": true,
        "drug_count": 1,
        "pathway_count": 3,
        "function_count": 2,
        "multimodal_score": 11
      }
    ],
    "multimodal_statistics": {
      "mean_multimodal_score": 12.333333333333334,
      "highly_integrated_genes": 3
    },
    "pathway_drug_associations": [
      {
        "pathway": "Nuclear Envelope Reassembly",
        "drug_id": "4344",
        "association_strength": 1
      },
      {
        "pathway": "SUMO modification",
        "drug_id": "4344",
        "association_strength": 1
      },
      {
        "pathway": "Cell cycle regulation",
        "drug_id": "4344",
        "association_strength": 1
      },
      {
        "pathway": "Glycosylation",
        "drug_id": "7892",
        "association_strength": 1
      },
      {
        "pathway": "Galactose metabolism",
        "drug_id": "7892",
        "association_strength": 1
      },
      {
        "pathway": "ER-Golgi transport",
        "drug_id": "7892",
        "association_strength": 1
      },
      {
        "pathway": "Autophagy",
        "drug_id": "2341",
        "association_strength": 1
      },
      {
        "pathway": "Autophagy",
        "drug_id": "8934",
        "association_strength": 1
      },
      {
        "pathway": "Lysosomal protein degradation",
        "drug_id": "2341",
        "association_strength": 1
      },
      {
        "pathway": "Lysosomal protein degradation",
        "drug_id": "8934",
        "association_strength": 1
      },
      {
        "pathway": "Antigen processing",
        "drug_id": "2341",
        "association_strength": 1
      },
      {
        "pathway": "Antigen processing",
        "drug_id": "8934",
        "association_strength": 1
      }
    ],
    "function_drug_associations": [
      {
        "molecular_function": "ATP binding",
        "drug_id": "4344",
        "association_strength": 1
      },
      {
        "molecular_function": "SUMO conjugating enzyme activity",
        "drug_id": "4344",
        "association_strength": 1
      },
      {
        "molecular_function": "protein binding",
        "drug_id": "4344",
        "association_strength": 1
      },
      {
        "molecular_function": "UDP-galactose transmembrane transporter activity",
        "drug_id": "7892",
        "association_strength": 1
      },
      {
        "molecular_function": "carbohydrate transmembrane transporter activity",
        "drug_id": "7892",
        "association_strength": 1
      },
      {
        "molecular_function": "cysteine-type endopeptidase activity",
        "drug_id": "2341",
        "association_strength": 1
      },
      {
        "molecular_function": "cysteine-type endopeptidase activity",
        "drug_id": "8934",
        "association_strength": 1
      },
      {
        "molecular_function": "peptidase activity",
        "drug_id": "2341",
        "association_strength": 1
      },
      {
        "molecular_function": "peptidase activity",
        "drug_id": "8934",
        "association_strength": 1
      }
    ],
    "clinical_summary": "Most complex therapeutic target: CTSL (multimodal score: 14). Multi-target therapeutic strategies recommended for high-complexity genes."
  },
  "clinical_biomarkers": {
    "biomarker_candidates": [
      {
        "gene_symbol": "CTSL",
        "transcript_id": "ENST00000343150.10",
        "biomarker_score": 107.68,
        "characteristics": [
          "drug_targetable",
          "multi_pathway",
          "autosomal"
        ],
        "chromosome": "chr9",
        "drug_count": 2,
        "pathway_count": 3,
        "function_count": 2
      },
      {
        "gene_symbol": "UBE2I",
        "transcript_id": "ENST00000566587.6",
        "biomarker_score": 105.4,
        "characteristics": [
          "drug_targetable",
          "multi_pathway",
          "multi_functional",
          "autosomal"
        ],
        "chromosome": "chr16",
        "drug_count": 1,
        "pathway_count": 3,
        "function_count": 3
      },
      {
        "gene_symbol": "SLC35A2",
        "transcript_id": "ENST00000634461.1",
        "biomarker_score": 75.68,
        "characteristics": [
          "drug_targetable",
          "multi_pathway"
        ],
        "chromosome": "chrX",
        "drug_count": 1,
        "pathway_count": 3,
        "function_count": 2
      }
    ],
    "biomarker_categories": {
      "high_potential": 3,
      "moderate_potential": 0,
      "emerging_biomarkers": 0
    },
    "top_biomarkers": [
      {
        "gene_symbol": "CTSL",
        "transcript_id": "ENST00000343150.10",
        "biomarker_score": 107.68,
        "characteristics": [
          "drug_targetable",
          "multi_pathway",
          "autosomal"
        ],
        "chromosome": "chr9",
        "drug_count": 2,
        "pathway_count": 3,
        "function_count": 2
      },
      {
        "gene_symbol": "UBE2I",
        "transcript_id": "ENST00000566587.6",
        "biomarker_score": 105.4,
        "characteristics": [
          "drug_targetable",
          "multi_pathway",
          "multi_functional",
          "autosomal"
        ],
        "chromosome": "chr16",
        "drug_count": 1,
        "pathway_count": 3,
        "function_count": 3
      },
      {
        "gene_symbol": "SLC35A2",
        "transcript_id": "ENST00000634461.1",
        "biomarker_score": 75.68,
        "characteristics": [
          "drug_targetable",
          "multi_pathway"
        ],
        "chromosome": "chrX",
        "drug_count": 1,
        "pathway_count": 3,
        "function_count": 2
      }
    ],
    "biomarker_statistics": {
      "mean_biomarker_score": 96.25333333333334,
      "score_distribution": {
        "high": 3,
        "moderate": 0,
        "emerging": 0
      }
    },
    "clinical_summary": "Top biomarker candidate: CTSL (score: 107.7). Immediate clinical validation studies recommended for high-scoring candidates."
  },
  "executive_summary": {
    "key_findings": [
      "2 high-priority drug targets identified",
      "9 altered pathways detected",
      "3 high-potential biomarker candidates"
    ],
    "clinical_priorities": [
      "Pathway-targeted therapeutic intervention"
    ],
    "therapeutic_opportunities": [
      "Precision medicine targeting of high-score drug-gene interactions"
    ],
    "recommended_actions": [
      "Initiate clinical validation studies for top biomarker candidates"
    ]
  }
}